Savara Pharma Raises Series A

Savara Pharmaceuticals, an Austin, Texas-based developer of inhalation drug delivery solutions, has raised an undisclosed amount of Series A funding. A regulatory filing indicates that the company was raising $1.4 million. No investor information was disclosed.

10 June 2009•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail